Patents by Inventor Elliad Ronen Silcoff

Elliad Ronen Silcoff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Agent for use in the case of fructose intolerance
    Patent number: 10568942
    Abstract: 5-D-fructose dehydrogenase, optionally in combination with invertase and/or maltase and/or glucose isomerase, may be used to treat fructose intolerance. Other embodiments are also disclosed.
    Type: Grant
    Filed: September 19, 2016
    Date of Patent: February 25, 2020
    Assignee: PRO NATURA GESELLSCHAFT FÜR GESUNDE ERNÄHRUNG MBH
    Inventors: Daniel Henry Wyrobnik, Isaac Harry Wyrobnik, Elliad Ronen Silcoff
  • AGENT FOR USE IN THE CASE OF FRUCTOSE INTOLERANCE
    Publication number: 20180344818
    Abstract: 5-D-fructose dehydrogenase, optionally in combination with invertase and/or maltase and/or glucose isomerase, may be used to treat fructose intolerance. Other embodiments are also disclosed.
    Type: Application
    Filed: September 19, 2016
    Publication date: December 6, 2018
    Inventors: Daniel Henry WYROBNIK, Isaac Harry WYROBNIK, Elliad Ronen SILCOFF
  • Agent for use in the case of fructose intolerance
    Patent number: 9446101
    Abstract: 5-D-fructose dehydrogenase, optionally in combination with invertase and/or maltase and/or glucose isomerase, may be used to treat fructose intolerance. Other embodiments are also disclosed.
    Type: Grant
    Filed: November 12, 2012
    Date of Patent: September 20, 2016
    Assignee: Pro Natura Gesellschaft fur gesunde Ernahrung mbH
    Inventors: Daniel Henry Wyrobnik, Isaac Harry Wyrobnik, Elliad Ronen Silcoff
  • AGENT FOR REDUCING THE USEABLE CALORIE CONTENT OF FOOD AND FOR THERAPEUTIC REDUCTION OF WEIGHT, IN PARTICULAR FOR USE IN THE CASE OF ADIPOSITY (OBESITY)
    Publication number: 20160175404
    Abstract: There are disclosed compositions and methods for treating obesity using 5-D-fructose dehydrogenase. Other embodiments are also described.
    Type: Application
    Filed: November 19, 2015
    Publication date: June 23, 2016
    Inventors: Daniel Henry WYROBNIK, Isaac Harry WYROBNIK, Elliad Ronen SILCOFF
  • AGENT FOR USE IN THE CASE OF FRUCTOSE INTOLERANCE
    Publication number: 20090081300
    Abstract: The present invention refers to an agent for use in the case of fructose intolerance and any form of impairment and affliction of health and well being which is caused by the administration of fructose or fructose containing foodstuffs or by the release of fructose in the digestive tract of humans or animals from other substances, such as e.g. sucrose. The agent according to the invention comprises 5-D-fructose dehydrogenase, optionally in combination with invertase and/or maltase and/or glucose isomerase, which enzyme or combination of enzymes is/are used in the medical field for the first time. Preferably the agent is in the form of a pharmaceutical composition which is useful for treatment of fructose intolerance.
    Type: Application
    Filed: November 15, 2006
    Publication date: March 26, 2009
    Applicant: PRO NATURA GESELLSCHAFT FUER GESUNDE ERNAEHRUNG MB
    Inventors: Daniel Henry Wyrobnik, Isaac Harry Wyrobnik, Elliad Ronen Silcoff
  • AGENT FOR REDUCING THE USEABLE CALORIE CONTENT OF FOOD AND FOR THERAPEUTIC REDUCTION OF WEIGHT, IN PARTICULAR FOR USE IN THE CASE OF ADIPOSITY (OBESITY)
    Publication number: 20090060956
    Abstract: An agent for reducing the useable calorie content of food is described which contains a compound effecting the dehydrogenation of fructose to 5-keto-D-fructose. In addition, a combination agent is described which also contains a compound that converts glucose to fructose. These agents can be used in particular in the therapy of adiposity (obesity).
    Type: Application
    Filed: November 23, 2006
    Publication date: March 5, 2009
    Inventors: Daniel Henry Wyrobnik, Isaac Harry Wyrobnik, Elliad Ronen Silcoff